PLAU and neoplasm: Although the temporally dispersed, repetitive approach used in this study resulted in a favorable adverse effect profile, the rapidly induced host immune response may have significantly and negatively decreased the anti-tumor effects of the rLAS-uPA therapy [7,8,9,29].